Stockscreener 앱 받기
2.09
5.00%
-0.11
시장 영업 전:
2.04
-0.05
-2.39%
Phio Pharmaceuticals Corp 주식(PHIO)의 최신 뉴스
Phio Pharmaceuticals Corp. Announces Positive Safety Monitoring Committee Recommendation to continue to Third Dose Cohort in its Clinical Study of PH-762 - Marketscreener.com
Phio Pharmaceuticals Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - Newsfile
Phio Pharmaceuticals Announces $480K Direct Offering with Warrant Coverage to Boost Working Capital - StockTitan
Phio Pharmaceuticals Rallies Following Key Trial and Funding Updates - Stocks Telegraph
Why Rumble Shares Are Trading Higher By Around 43%; Here Are 20 Stocks Moving Premarket - Benzinga
As FedEx plans to spin off freight, can it cut costs even more? - Yahoo Finance
Phio stock hits 52-week low at $2.13 amid market challenges - Investing.com
Phio Pharmaceuticals Raises $1.15M Through Strategic Direct Offering and Warrant Placement - StockTitan
Franklin Resources (BEN-N) QuotePress Release - The Globe and Mail
Phio Pharmaceuticals Announces Positive Safety Monitoring Committee (SMC) Recommendation to Continue to Third Dose Cohort in its Clinical Study of PH-762 - Newsfile
Phio Pharmaceuticals Reports Complete Tumor Clearance in Phase 1b Cancer Trial: Key Clinical Data Released - StockTitan
Fed is weighing impact of Trump's proposed tariffs, Powell signals - Yahoo Finance
It's 'critical' home builders 'ramp up production': NAR economist - Yahoo Finance
Wall Street awaits Fed rate cut, expecting cautious tone for 2025 - Yahoo Finance
Bitcoin, 'super-bullish' sentiment, Axon: Asking for a Trend - Yahoo Finance
TCW Sticks to Bond wager Despite Losses - Yahoo Finance
Tesla clinches another record high after new bullish price targets from Wall Street - Yahoo! Voices
Broadcom stock eases on post-earnings rally as Nvidia tumbles - Yahoo Finance
Inheritance & savings: Planning challenges for LGBTQ+ individuals - Yahoo Finance
2025 will be 'a renter's market.' Redfin economist explains why. - Yahoo Finance
Phio Pharmaceuticals Announces Publication in Frontiers in Immunology - Yahoo Finance
US has a 'sickcare system,' not a healthcare system: Anomaly CEO - Yahoo Finance
Phio Pharmaceuticals is a Finalist for the Technology Disruptor of the Year Award - StockTitan
D.R. Horton (DHI-N) QuotePress Release - The Globe and Mail
Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-Deal Roadshow Series - Newsfile
Phio Pharmaceuticals to Present at Renmark Financial Virtual Roadshow - StockTitan
Elite Pharmaceuticals Announces Commercial Launch of Acetaminophen and Hydrocodone Tablets - Yahoo Finance
Phio Pharmaceuticals Announces Completion of Enrollment in Second - The Kingston Whig-Standard
Phio Pharmaceuticals Announces Completion of Enrollment in Second Cohort in Phase 1b Dose-Escalating Clinical Study - Newsfile
Phio Pharmaceuticals Corp. (PHIO) Quarterly 10-Q Report - Quartzy
Phio Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update - Alberta Daily Herald Tribune
Phio Pharma Reports 100% Tumor Clearance in Phase 1b Trial, Cuts Q3 Net Loss by 46% | PHIO Stock News - StockTitan
Phio Pharmaceuticals Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
PHIO stock touches 52-week low at $2.38 amid market challenges - Investing.com
Ligand Pharmaceuticals Inc (LGND) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ... - Yahoo Finance
PHIOPhio Pharmaceuticals Corp. Latest Stock News & Market Updates - StockTitan
Phio Pharmaceuticals Announces Upcoming Presentation at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) - Newsfile
IMAX Corporation (IMAX) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance
Phio Pharmaceuticals Announces Upcoming Presentation at the 39th - Shoreline Beacon
Correction to Registration Link to Access Phio Pharmaceuticals' Presentation in the Renmark Financial Communications Virtual Non-Deal Roadshow Series - Newsfile
Non-melanoma Skin Cancer is Predicted to Exhibit Remarkable - GlobeNewswire
Financial Analysis: Dianthus Therapeutics (NASDAQ:DNTH) and Phio Pharmaceuticals (NASDAQ:PHIO) - Defense World
Nasdaq Financial 100 Index (IXF) QuotePress Release - The Globe and Mail
Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-deal Roadshow Series - StockTitan
Dry Age-Related Macular Degeneration Market to Reach USD 10.57 Billion by 2032 with 9.1% CAGR – SNS Insider - GlobeNewswire
Phio Pharmaceuticals presents novel cancer therapy data - Investing.com
Phio Pharmaceuticals presents novel cancer therapy data By Investing.com - Investing.com South Africa
Phio Pharmaceuticals Presenting Data on Its INSTAYL Compound PH-894 at ASGCT's 2024 Advancing Gene and Cell Therapies for Cancer Conference - Newsfile
Phio Pharmaceuticals Presenting Data on Its INSTAYL Compound PH-894 - The Kingston Whig-Standard
Tonix Pharma Enhances Drug Development with AI Partnership - Yahoo Finance
Understanding the Risks of Investing in Phio Pharmaceuticals Corp (PHIO) - Knox Daily
0.50%
1.47%
자본화:
|
볼륨(24시간):